Cytosorbents Crp (CTSO) — Capital Reinvestment Ratio
Latest as of June 2020:
0.26x
Cytosorbents Crp (CTSO) has a Capital Reinvestment Ratio of 0.26x as of June 2020, meaning it reinvests 0% of its operating cash flow ($1.94 Million) in capital expenditures ($497.36K). Check Cytosorbents Crp (CTSO) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
0.26x
Capex / Operating Cash Flow
Operating Cash Flow
$1.94 Million
USD
Capital Expenditures
$497.36K
USD
Data as of
Jun 2020
Most recent filing
Annual Capital Reinvestment Ratio for Cytosorbents Crp (None–None)
Year-by-year Capital Reinvestment Ratio for Cytosorbents Crp from None to None. See CTSO free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow